Weikang Bio-Technology Group Co., Inc. is a Chinese producer of Over-the-Counter (OTC) pharmaceuticals and traditional Chinese medicine (TCM) products. Trading on NASDAQ’s OTCBB, the Company currently has 420 employees. With headquarters in Harbin, China, the company has production facilities in Harbin and Guiyang.

Weikang Bio-Technology Company, Inc. received incorporation in Florida on May 12, 2004 as Expedition Leasing, Inc. On December 7, 2007, the Company acquired Sinary Bio-Technology Holdings Group, Inc. and Sinary’s wholly owned subsidiary Heilongjiang Weikang Bio-Technology Group Co., Ltd., a limited liability company in China.

Sinary, with no substantive operations that they conduct, through Heilongjiang Weikang engages in the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine (TCM) in China. All of the Company’s products are Chinese herbal-based health and nutritional supplements. They actively look to maintain and improve the quality of their products, and as of April 2006, they have implemented the “GB/T19001-2000 idt ISO9001:2000″ quality-assurance management system to all of their manufacturing processes.

Heilongjiang Weikang is located in Heilongjiang Province in Northeastern China. Their principal office and manufacturing facility is in the Economic and Technology Development Zone in the city of Shuangcheng, approximately 42 kilometers south of the provincial capital Harbin.

Through Heilongjiang Weikang, they manufacture and distribute in China a series of internally developed health supplements under a Chinese trade name. Its English transliteration is “Rongrun”. The “Rongrun” line currently includes seven products. They also developed two new products during 2007 which received approval from the Heilongjiang Department of Health.

On July 22, 2008, Heilongjiang Weikang acquired 100 percent of the issued and outstanding equity interest of Tianfang (Guizhou) Pharmaceutical Co., Ltd., a Chinese limited liability company. Tianfang received incorporation in Guizhou Province, China in 1998. Tianfang engages in the development, manufacture, and distribution of OTC Pharmaceuticals.